Cell Therapy Catapult strikes manufacturing deal with Loughborough

The Technology Strategy Board's Cell Therapy Catapult and Loughborough University have announced plans to work together to develop manufacturing processes for cell-based therapies.

The aim of the collaboration is to increase knowledge of how to ensure reproducibility, purity, potency and efficacy in the manufacturing process.

Catapult chief executive Keith Thompson said: “This is one of the fundamental translational gaps that the CT catapult is working to bridge, providing the cell therapy industry with important advances, and the expertise available at the [university’s Centre for Biological Engineering] will be invaluable for this task.”